CV Sciences (CVSI) Accumulated Expenses (2010 - 2026)
CV Sciences (CVSI) posted Accumulated Expenses of $2.6 million for Q1 2026, up 8.17% sequentially from $2.4 million in Q4 2025, and up 91.81% YoY from $1.4 million in Q1 2025.
CV Sciences (CVSI) Accumulated Expenses (2010 - 2026) Analysis & Trends
CV Sciences has reported Accumulated Expenses for 15 years, with the latest figure at $2.6 million in Q1 2026.
- Quarterly Accumulated Expenses rose 91.81% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 91.81% YoY) and the FY2025 annual result came in at $2.4 million, up 368.77% from the prior year.
- Accumulated Expenses improved to $2.6 million in Q1 2026 per CVSI's latest filing, from $2.4 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $10.3 million in Q1 2022 and troughed at $500000.0 in Q1 2023.
- A 5-year average of $3.8 million and a median of $2.9 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses plunged 95.13% in 2023, then surged 549.6% in 2024.
- Over 5 years, Accumulated Expenses stood at $6.7 million in 2022, then slumped by 92.21% to $522000.0 in 2023, then changed by 0.0% to $522000.0 in 2024, then surged by 368.77% to $2.4 million in 2025, then rose by 8.17% to $2.6 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $2.6 million, $2.4 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | CV Sciences | 3.90 Mn | 3.63 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.63 Mn |
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 522,000.00 |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 522,000.00 |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 6.70 Mn |
| Sep 30, 2022 | 9.72 Mn |
| Jun 30, 2022 | 9.93 Mn |
| Mar 31, 2022 | 10.28 Mn |
| Dec 31, 2021 | 10.92 Mn |
| Sep 30, 2021 | 10.80 Mn |
| Jun 30, 2021 | 10.23 Mn |